FDA Advisory Panel Rejects Controversial Alzheimer's Drug

By Jon Hamilton

Published November 6, 2020 at 5:10 PM EST

Jon Hamilton

Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.